Distribution of the HIV-1 resistance-conferring alleles (CCR5delta32, CCR2-64I, and SDF1 3′A) in Russian, Ukrainian, and Belarusian populations

Genetika

Volumn 40, Issue 10, 2004, Pages 1394-1401

  Kozhekbaeva, Zh M ^a   Borodina, T A ^a,b   Borinskaya, S A ^a   Gusar, V A ^c   Feschenko, S P ^d   Akhmetova, V L ^e   Khusainova, R I ^e   Gupalo, E Yu ^a   Spitsyn, V A ^f   Grechanina, E J ^c   Khusnutdinova, E K ^e   Yankovsky, N K ^a  

^a VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c Kharkov Regional Center of Clinical Genetics and Prenatal Diagnostics   (Ukraine)

^d Natl Res Inst Hered/Inborn Dis   (Belarus)

^e INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

^f RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; PROTEIN CCR2 64I; PROTEIN CCR5 DELTA32; PROTEIN SDF1 3'A; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; MONOCYTE CHEMOATTRACTANT PROTEIN 1 RECEPTOR; STROMAL CELL DERIVED FACTOR 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; BELARUS; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; POPULATION RESEARCH; RUSSIAN FEDERATION; UKRAINE; VIRUS RESISTANCE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; RISK FACTOR;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; BYELARUS; CHEMOKINES, CXC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HIV-1; HUMANS; MALE; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RISK FACTORS; RUSSIA; UKRAINE;

EID: 28744448168     PISSN: 00166758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Anderson R.M., May R.M., Boily M.C. et al. The spread of HIV-1 in Africa: Sexual contact patterns and the predicted demographic impact of AIDS // Nature. 1991. V. 352. P. 581-589.
2. Carael M., Buve A., Awusabo-Asare K. The making of HIV epidemics: What are the driving forces? // AIDS. 1997. V. 11. Suppl B. P. S23-S31.
3. Magierowska M., Theodorou I., Debre P. et al. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals // Blood. 1999. V. 93. P. 936-941.
4. Cooke G. S., Hill A.V.S. Genetics of susceptibility to human infectious disease // Nature Rev. Genetics. 2001. V. 2. P. 967-977.
5. Winkler C., An P., O'Brien S.J. Patterns of ethnic diversity among the genes that influence AIDS // Hum. Molec. Genet. 2004. V. 13. P. r9-r19.
6. Dean M., Carrington M., Winkler C. et al. Genetic resistance of HIV infection and progression to AIDS by deletion of the CKR5 structural gene // Science. 1996. V. 273. P. 1856-1862.
7. Dean M., Carrington M., O'Brien S.J. Balanced polymorphism selected by genetic versus infectious human disease // Ann. Rev. Genomics and Human Genetics. 2002. V. 3. P. 263-292.
8. Bleul C.C., Farzan M., Choe H. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry // Nature. 1996. V. 382. P. 829-833.
9. Feng Y., Broder C.C., Kennedy P.E., Berger EA. HIV-1 entry cofactor: Functional cDNA cloning of seven-transmembrane F protein-coupled receptor // Science. 1996. V. 272. P. 872-877.
10. Huang Y., Paxton WA., Wolinsky S.M. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression // Nature Med. 1996. V. 2. P. 1240-1243.
11. Liu R., Paxton WA., Choe S. et al. Homozygous defect in HIV co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection // Cell. 1996. V. 86. P. 367-377.
12. Smith M.W., Dean M., Carrington M. et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression // Science. 1997. V. 277. P. 959-965.
13. Winkler C., Modi W., Smith M.W. et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant // Science. 1998. V. 279. P. 389-393.
14. Ioannidis J.P., Rosenberg P.S., Goedert J.J. et al. Effects of CCR5-delta32, CCR2-64I, and SDF1-3′A alleles on HIV-1 disease progression: An international metaanalysis of individual-patient data // Ann. Intern. Med. 2001. V. 135. P. 782-795.
15. Michael N.L., Lougie L.G., Rohrbaugh A.L. et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression // Nature Med. 1997. V. 3. P. 1150-1162.
16. Woitas R.P., Ahlenstiel G., Iwan A. et al. Do polymorphisms of the SDF1 and CCR2 genes modify the course of hepatitis C or HIV/HCV co-infection? // Dtsch. Med. Wochenschr. 2002. V. 127. P. 1807-1812.
17. Mulherin S.A., O'Brien T.R., Ioannidis J.P. et al. International meta-analysis of HIV host genetics. Effects of CCR5-delta32 and CCR2-64I alleles on HIV-1 disease progression: The protection varies with duration of infection // AIDS. 2003. V. 17. P. 377-387.
18. U.S. Centers for Disease Control // Morb. Mortal. Wkly. Rep. 41 (18 December), 1992.
19. Stephens J.C., Reich D.E., Goldstein D.B. et al. Dating the origin of the CCR5-delta32 AIDS resistance gene allele by the coalescence of haplotypes // Am. J. Hum. Genet. 1998. V. 62. P. 1507-1515.
20. (Aseev M.V., Shawi A., Dean M., Baranov V.S. Population frequencies of the CKR5 mutant allele of the chemokine receptor gene responsible // Rus. J. Genetics. 1997. V. 33. No 12. P. 1475-1477.)
21. (Ryabov G.S., Kazennova E.V., Bobkov A.F. Frequencies of the CCR2-641 and SDFl-3′A alleles associated with progression of the HIV-1 disease in healthy individuals from Moscow // Rus. J. Genetics. 2002. V. 38. No 2. P. 213-215.)
22. Limborska S.A., Balanovsky O.P., Balanovskaya E.V. et al. Analysis of CCR5delta32 geographic distribution and its correlation with some climatic and geographic factors // Hum. Hered. 2002. V. 53. P. 49-54.
23. Kalev I., Mikelsaar A.V., Beckman L. et al. High frequency of the HIV-1 protective CCR5delta32 deletion in native Estonians // Eur. J. Epidemiol. 2000. V. 16. P. 1107-1109.
24. Martinson J.J., Chapman N.H., Rees D.C. et al. Global distribution of the CCR5 gene 32-basepair deletion // Nat. Genet. 1997. V. 16. P. 100-103.
25. Libert F., Cochons P., Beckman G. et al. The CCR5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe // Hum. Mol. Genet. 1998. V. 7. P. 399-406.
26. Su B., Sun G., Lu D. et al. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3′A, CCR2-641, and CCR5-delta32) in global populations // Eur. J. Hum. Genet. 2000. V. 8. P. 975-979.
27. Ramana G.V., Vasanthi A., Khaja M. et al. Distribution of HIV-1 resistance-conferring polymorphic alleles SDF1-3′A, CCR2-641 and CCR5-delta32 in diverse populations of Andhra Pradesh, South India // J. Genet. 2001. V. 80. P. 137-140.
28. Jagodzinski P.P., Lecybyl R., Ignacak M. et al. Distribution of 32 alelle of the CCR5 gene in the population of Poland // J. Hum. Genet. 2000. V. 45. P. 271-274.
29. Yudin N.S., Vinogradov S.V., Potapova T.A. et al. Distribution of CCR5delta 32 gene deletion across the Russian part of Eurasia // Hum. Genet. 1998. V. 102. P. 695-698.
30. Eugen-Olsen J., Iversen A.K., Benfield T.L. et al. Chemokine receptor CCR2b-64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort // J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998. V. 18. Ms 2. P. 110-116.
31. Martinson J.J., Hong L., Karanicolas R. et al. Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype // AIDS. 2000. V. 14. P. 483-489.
32. Struyf F., Thoelen I., Charlier N. et al. Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium // Hum. Hered. 2000. V. 50. P. 304-307.
33. Romano-Spica V., Ianni A., Arzani D. et al. Allelic distribution of CCR5 and CCR2 genes in an Italian population sample // AIDS Res. Hum. Retroviruses. 2000. V. 16. P. 99-101.
34. Royo J.L., Ruiz A., Borrego S. et al. Fluorescence resonance energy transfer analysis of CCR-V64I and SDF1-3′A polymorphisms: Prevalence in southern Spain hiv type 1 + cohort and noninfected population // AIDS Res. Hum. Retroviruses. 2001. V. 17. P. 663-666.
35. Lewandowska M., Franciszkiewicz K., Prokop J. et al. Distribution of two HIV-1-resistant polymorphisms (SDF1-3′A and CCR2-64I alleles) in the Polish population // J. Hum. Genet. 2002. V. 47. P. 585-589.
36. Du Q., Wang F., Hong W. et al. Polymorphisms of chemokine receptor alleles influencing genetic susceptibility to HIV-1 infection in Mongolia population in China // Zhonghua Liu Xing Bing Xue Za Zhi. 2000. V. 21. P. 413-416.
37. Hong W., Wang F., Jin L. et al. Genotyping of HIV resistant alleles in indigenous Tibetan ethnic group of China: Low frequency of CCR5D32 and high frequency of CCR2b-64I alleles // Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001. V. 18. P. 268-271.
38. Nookhai S., Ruxrungtham K., Phanuphak P., Oelrichs R. Prevalence of CCR2-64I, SDF1-3′A and CCR5-delta32 alleles in healthy Thais // Eur. J. Immunogenet. 2000. V. 27. P. 153-157.
39. Voevodin A., Samilchuk E., Dashti S. Frequencies of SDF-1 chemokine, CCR-5, and CCR-2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and AIDS in Kuwaitis // J. Med. Virol. 1999. V. 58. P. 54-58.
40. Wang F., Jin L., Lei Z. et al. Distribution of HIV resistance CCR5-delta32, CCR2-64I and SDF1-3′A alleles and their polymorphisms in the Han population in China // Zhonghua Liu Xing B ing Xue Za Zhi. 2000. V. 21. P. 256-260.
41. Petrek M., Drabek J., Kolek V. et al. CC Chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis // Am. J. Respir. Crit. Care Med. 2000. V. 162. No 3. P. 1000-1003.
42. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. N.Y.: Cold Spring Harbor Lab. Press, 1989. 479 p.
43. Schinkel J., Langendam M.W., Coutinho R.A. et al. No evidence for an effect of the CCR5delta32/+ and CCR2b-64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users // J. Infect. Dis. 1999. V. 179. No 4. P. 825-831.
44. (Slominskii P.A., Shadrina M.I., Spitsyn V.A. et al. A simple and rapid method for determining a 32-bp deletion in the gene for the chemokine receptor CCR5 // Rus. J. Genetics. 1997. V. 33. No 11. P. 1368-1370.)
45. Borodino T.A., Lehrach H., Soldatov A.V. Ligation-based synthesis of oligonucleotides with block structure // Anal. Biochem. 2003. V. 318. No 2. P. 309-313.
46. 2 and problem of small samples // Mol. Biol. Evol. 1989. V. 6. P. 539-545.
47. McDermott D.H., Zimmerman P.A., Guignard F. et al. CCR5 promoter polymorphism and HIV-1 disease progression // The Lancet. 1998. V. 352. P. 866-870.
48. Martin M.P., Dean M., Smith M.W. Genetic acceleration of AIDS progression by a promoter variant of CCR5 // Science. 1998. V. 282. P. 1907-1911.
49. Gonzalez E., Mabshad M., Sato N. et al. Race-specific HIV-a disease-modifying effects associated with CCR5 haplotypes // Proc. Natl Acad. Sci. USA. 1998. V. 96. P. 12004-12009.